| Symbol |
Name |
Standardized Value |
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
3.332
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
3.035
|
|
EPAS1
|
endothelial PAS domain protein 1
|
3.018
|
|
MEN1
|
multiple endocrine neoplasia I
|
2.943
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
2.939
|
|
NF1
|
neurofibromin 1
|
2.934
|
|
ELOC
|
elongin C
|
2.909
|
|
TMEM127
|
transmembrane protein 127
|
2.902
|
|
ELOB
|
elongin B
|
2.837
|
|
CUL2
|
cullin 2
|
2.787
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
2.693
|
|
RET
|
ret proto-oncogene
|
2.692
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
2.658
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
2.567
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
2.538
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
2.515
|
|
EIF5B
|
eukaryotic translation initiation factor 5B
|
2.487
|
|
CHGA
|
chromogranin A
|
2.48
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
2.451
|
|
VHLL
|
von Hippel-Lindau tumor suppressor-like
|
2.402
|
|
CA9
|
carbonic anhydrase IX
|
2.398
|
|
SYP
|
synaptophysin
|
2.392
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
2.376
|
|
TSC2
|
tuberous sclerosis 2
|
2.365
|
|
FLCN
|
folliculin
|
2.329
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
2.324
|
|
SST
|
somatostatin
|
2.321
|
|
FH
|
fumarate hydratase
|
2.32
|
|
EPO
|
erythropoietin
|
2.309
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
2.26
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
2.22
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
2.198
|
|
TP53
|
tumor protein p53
|
2.145
|
|
NF2
|
neurofibromin 2 (merlin)
|
2.121
|
|
PBRM1
|
polybromo 1
|
2.118
|
|
CD34
|
CD34 molecule
|
2.112
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
2.109
|
|
PAX8
|
paired box 8
|
2.101
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
2.097
|
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
2.089
|
|
GAST
|
gastrin
|
2.073
|
|
KIF1B
|
kinesin family member 1B
|
2.07
|
|
TCHP
|
trichoplein, keratin filament binding
|
2.059
|
|
MAX
|
MYC associated factor X
|
2.058
|
|
MDH2
|
malate dehydrogenase 2, NAD (mitochondrial)
|
2.042
|
|
PTEN
|
phosphatase and tensin homolog
|
2.014
|
|
PPY
|
pancreatic polypeptide
|
2.013
|
|
DAXX
|
death-domain associated protein
|
2.012
|
|
SETD2
|
SET domain containing 2
|
2.007
|
|
VIP
|
vasoactive intestinal peptide
|
2.001
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.998
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
1.995
|
|
TGFA
|
transforming growth factor, alpha
|
1.98
|
|
MME
|
membrane metallo-endopeptidase
|
1.975
|
|
BRK1
|
BRICK1, SCAR/WAVE actin-nucleating complex subunit
|
1.931
|
|
JADE1
|
jade family PHD finger 1
|
1.923
|
|
SLC25A11
|
solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11
|
1.911
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.896
|
|
SSTR2
|
somatostatin receptor 2
|
1.89
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
1.879
|
|
KDR
|
kinase insert domain receptor
|
1.866
|
|
KRT7
|
keratin 7, type II
|
1.864
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.861
|
|
PAX2
|
paired box 2
|
1.858
|
|
TSC1
|
tuberous sclerosis 1
|
1.855
|
|
GCG
|
glucagon
|
1.849
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.847
|
|
BRCA1
|
breast cancer 1, early onset
|
1.837
|
|
PDPN
|
podoplanin
|
1.836
|
|
GFAP
|
glial fibrillary acidic protein
|
1.827
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
1.827
|
|
SLC49A4
|
solute carrier family 49 member 4
|
1.827
|
|
POLR2G
|
polymerase (RNA) II (DNA directed) polypeptide G
|
1.819
|
|
EGFR
|
epidermal growth factor receptor
|
1.815
|
|
EPOR
|
erythropoietin receptor
|
1.806
|
|
BRCA2
|
breast cancer 2, early onset
|
1.795
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.792
|
|
CSDE1
|
cold shock domain containing E1, RNA-binding
|
1.767
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
1.767
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.764
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
1.755
|
|
USP33
|
ubiquitin specific peptidase 33
|
1.749
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.734
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.728
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.725
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.724
|
|
MUTYH
|
mutY homolog
|
1.722
|
|
POMC
|
proopiomelanocortin
|
1.721
|
|
KDM5C
|
lysine (K)-specific demethylase 5C
|
1.705
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.691
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.675
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.67
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.665
|
|
FNIP1
|
folliculin interacting protein 1
|
1.662
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
1.661
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
1.648
|
|
INS
|
insulin
|
1.635
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.633
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.629
|
|
CHEK2
|
checkpoint kinase 2
|
1.628
|
|
STK11
|
serine/threonine kinase 11
|
1.604
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.598
|
|
P4HA1
|
prolyl 4-hydroxylase, alpha polypeptide I
|
1.587
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
1.584
|
|
SDHAF1
|
succinate dehydrogenase complex assembly factor 1
|
1.582
|
|
SSTR5
|
somatostatin receptor 5
|
1.58
|
|
VBP1
|
von Hippel-Lindau binding protein 1
|
1.57
|
|
MLH1
|
mutL homolog 1
|
1.57
|
|
CCND1
|
cyclin D1
|
1.553
|
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II
|
1.551
|
|
DCAF4L1
|
DDB1 and CUL4 associated factor 4-like 1
|
1.547
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
1.539
|
|
MSH2
|
mutS homolog 2
|
1.532
|
|
CA12
|
carbonic anhydrase XII
|
1.525
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
1.523
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
1.522
|
|
USP20
|
ubiquitin specific peptidase 20
|
1.52
|
|
FNIP2
|
folliculin interacting protein 2
|
1.516
|
|
NEK8
|
NIMA-related kinase 8
|
1.512
|
|
ATM
|
ATM serine/threonine kinase
|
1.51
|
|
IFNA17
|
interferon, alpha 17
|
1.496
|
|
KIAA1549
|
KIAA1549
|
1.493
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.485
|
|
MAML3
|
mastermind-like 3 (Drosophila)
|
1.483
|
|
IFNA1
|
interferon, alpha 1
|
1.483
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.482
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
1.474
|
|
EP300
|
E1A binding protein p300
|
1.468
|
|
IFNA10
|
interferon, alpha 10
|
1.465
|
|
IFNA7
|
interferon, alpha 7
|
1.465
|
|
IFNA14
|
interferon, alpha 14
|
1.465
|
|
IFNA16
|
interferon, alpha 16
|
1.465
|
|
IFNA8
|
interferon, alpha 8
|
1.464
|
|
IFNA6
|
interferon, alpha 6
|
1.464
|
|
IFNA21
|
interferon, alpha 21
|
1.464
|
|
IFNA2
|
interferon, alpha 2
|
1.463
|
|
IFNA5
|
interferon, alpha 5
|
1.463
|
|
IFNA13
|
interferon, alpha 13
|
1.462
|
|
FN1
|
fibronectin 1
|
1.462
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.46
|
|
IFNA4
|
interferon, alpha 4
|
1.459
|
|
TERT
|
telomerase reverse transcriptase
|
1.458
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
1.457
|
|
SCT
|
secretin
|
1.45
|
|
MSH6
|
mutS homolog 6
|
1.447
|
|
OFD1
|
oral-facial-digital syndrome 1
|
1.444
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.436
|
|
SMAD4
|
SMAD family member 4
|
1.431
|
|
GNAS
|
GNAS complex locus
|
1.43
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
1.43
|
|
PGF
|
placental growth factor
|
1.428
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.426
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
1.422
|
|
H3-3B
|
H3.3 histone B
|
1.412
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.411
|
|
KRT8
|
keratin 8, type II
|
1.411
|
|
RWDD3
|
RWD domain containing 3
|
1.41
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.406
|
|
GHRH
|
growth hormone releasing hormone
|
1.406
|
|
SHH
|
sonic hedgehog
|
1.402
|
|
WT1
|
Wilms tumor 1
|
1.396
|
|
FLT4
|
fms-related tyrosine kinase 4
|
1.395
|
|
TBXT
|
T-box transcription factor T
|
1.389
|
|
SSTR1
|
somatostatin receptor 1
|
1.386
|
|
CD99
|
CD99 molecule
|
1.386
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
1.384
|
|
IL2
|
interleukin 2
|
1.381
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.381
|
|
KRT20
|
keratin 20, type I
|
1.38
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
1.376
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
1.373
|
|
PALB2
|
partner and localizer of BRCA2
|
1.372
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.368
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.365
|
|
ELOA2
|
elongin A2
|
1.363
|
|
BPGM
|
2,3-bisphosphoglycerate mutase
|
1.361
|
|
CD99L2
|
CD99 molecule-like 2
|
1.359
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
1.342
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
1.341
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
1.338
|
|
REN
|
renin
|
1.334
|
|
NEK9
|
NIMA-related kinase 9
|
1.333
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.333
|
|
EGF
|
epidermal growth factor
|
1.329
|
|
IGF2
|
insulin-like growth factor 2
|
1.328
|
|
KIF3A
|
kinesin family member 3A
|
1.327
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
1.326
|
|
SKP1
|
S-phase kinase-associated protein 1
|
1.321
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
1.32
|
|
CUL1
|
cullin 1
|
1.32
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
1.318
|
|
CD274
|
CD274 molecule
|
1.316
|
|
ZNF814
|
zinc finger protein 814
|
1.316
|
|
SSTR3
|
somatostatin receptor 3
|
1.316
|
|
FHIT
|
fragile histidine triad
|
1.315
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
1.311
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
1.31
|
|
H3-3A
|
H3.3 histone A
|
1.31
|
|
PTCH1
|
patched 1
|
1.309
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.302
|
|
TFEB
|
transcription factor EB
|
1.298
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.297
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
1.293
|
|
PGR
|
progesterone receptor
|
1.292
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.282
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.282
|
|
MITF
|
microphthalmia-associated transcription factor
|
1.279
|
|
CA14
|
carbonic anhydrase XIV
|
1.278
|
|
CDC73
|
cell division cycle 73
|
1.273
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
1.269
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
1.268
|
|
CUL5
|
cullin 5
|
1.262
|
|
JAK2
|
Janus kinase 2
|
1.262
|
|
LDHA
|
lactate dehydrogenase A
|
1.26
|
|
PXDN
|
peroxidasin
|
1.258
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.257
|
|
PXDNL
|
peroxidasin-like
|
1.254
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.253
|
|
TH
|
tyrosine hydroxylase
|
1.253
|
|
PGK1
|
phosphoglycerate kinase 1
|
1.249
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.247
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.245
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
1.241
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.24
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.239
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.236
|
|
INVS
|
inversin
|
1.233
|
|
MAPKBP1
|
mitogen-activated protein kinase binding protein 1
|
1.233
|
|
EPHB4
|
EPH receptor B4
|
1.232
|
|
PTH
|
parathyroid hormone
|
1.231
|
|
H3C12
|
H3 clustered histone 12
|
1.23
|
|
AXL
|
AXL receptor tyrosine kinase
|
1.229
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.226
|
|
RHEB
|
Ras homolog enriched in brain
|
1.224
|
|
KRT19
|
keratin 19, type I
|
1.224
|
|
SLC18A1
|
solute carrier family 18 (vesicular monoamine transporter), member 1
|
1.219
|
|
USP8
|
ubiquitin specific peptidase 8
|
1.218
|
|
ACTB
|
actin, beta
|
1.211
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
1.202
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
1.201
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
1.201
|
|
UBE2S
|
ubiquitin-conjugating enzyme E2S
|
1.201
|
|
MLST8
|
MTOR associated protein, LST8 homolog (S. cerevisiae)
|
1.194
|
|
DICER1
|
dicer 1, ribonuclease type III
|
1.194
|
|
ALB
|
albumin
|
1.193
|
|
CD68
|
CD68 molecule
|
1.193
|
|
ELOA
|
elongin A
|
1.19
|
|
CALB2
|
calbindin 2
|
1.189
|
|
CEP68
|
centrosomal protein 68kDa
|
1.189
|
|
CHGB
|
chromogranin B
|
1.188
|
|
SMARCE1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
|
1.185
|
|
SSTR4
|
somatostatin receptor 4
|
1.181
|
|
GCGR
|
glucagon receptor
|
1.18
|
|
CCM2
|
cerebral cavernous malformation 2
|
1.175
|
|
FLT3
|
fms-related tyrosine kinase 3
|
1.175
|
|
CDK6
|
cyclin-dependent kinase 6
|
1.171
|
|
HNF1B
|
HNF1 homeobox B
|
1.17
|
|
H3-5
|
H3.5 histone
|
1.169
|
|
EWSR1
|
EWS RNA-binding protein 1
|
1.168
|
|
CUL3
|
cullin 3
|
1.168
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.167
|
|
CA5A
|
carbonic anhydrase VA, mitochondrial
|
1.166
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
1.163
|
|
H3C13
|
H3 clustered histone 13
|
1.161
|
|
PKM
|
pyruvate kinase, muscle
|
1.16
|
|
H3-4
|
H3.4 histone, cluster member
|
1.16
|
|
PRL
|
prolactin
|
1.158
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
1.157
|
|
EFNB2
|
ephrin-B2
|
1.156
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
1.153
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
1.151
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.15
|
|
CA7
|
carbonic anhydrase VII
|
1.145
|
|
FGF4
|
fibroblast growth factor 4
|
1.141
|
|
RAPH1
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
|
1.14
|
|
POU5F1
|
POU class 5 homeobox 1
|
1.138
|
|
LOX
|
lysyl oxidase
|
1.136
|
|
INSM1
|
insulinoma-associated 1
|
1.133
|
|
SFMBT1
|
Scm-like with four mbt domains 1
|
1.132
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.132
|
|
FGF6
|
fibroblast growth factor 6
|
1.132
|
|
FGF17
|
fibroblast growth factor 17
|
1.127
|
|
FGF18
|
fibroblast growth factor 18
|
1.124
|
|
FGF5
|
fibroblast growth factor 5
|
1.124
|
|
UMOD
|
uromodulin
|
1.122
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
1.121
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
1.12
|
|
FGF3
|
fibroblast growth factor 3
|
1.119
|
|
PDCD10
|
programmed cell death 10
|
1.118
|
|
FGF20
|
fibroblast growth factor 20
|
1.118
|
|
NPHP3
|
nephronophthisis 3 (adolescent)
|
1.117
|
|
FGF10
|
fibroblast growth factor 10
|
1.115
|
|
THRB
|
thyroid hormone receptor, beta
|
1.114
|
|
FGF22
|
fibroblast growth factor 22
|
1.111
|
|
FGF16
|
fibroblast growth factor 16
|
1.11
|
|
HOXD11
|
homeobox D11
|
1.109
|
|
BARD1
|
BRCA1 associated RING domain 1
|
1.108
|
|
GATA3
|
GATA binding protein 3
|
1.108
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.108
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
1.101
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
1.101
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
1.1
|
|
DAPK1
|
death-associated protein kinase 1
|
1.099
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.098
|
|
MXD1
|
MAX dimerization protein 1
|
1.096
|
|
ESR1
|
estrogen receptor 1
|
1.095
|
|
JUN
|
jun proto-oncogene
|
1.092
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
1.092
|
|
FGF9
|
fibroblast growth factor 9
|
1.092
|
|
DEPDC5
|
DEP domain containing 5
|
1.091
|
|
FGF7
|
fibroblast growth factor 7
|
1.091
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.09
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
1.089
|
|
RARB
|
retinoic acid receptor, beta
|
1.087
|
|
AFP
|
alpha-fetoprotein
|
1.085
|
|
PTHLH
|
parathyroid hormone-like hormone
|
1.083
|
|
PHLDA3
|
pleckstrin homology-like domain, family A, member 3
|
1.08
|
|
NKX2-1
|
NK2 homeobox 1
|
1.079
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.079
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
1.077
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
1.076
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.075
|
|
VIM
|
vimentin
|
1.071
|
|
CWC27
|
CWC27 spliceosome-associated protein homolog (S. cerevisiae)
|
1.069
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
1.065
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.064
|
|
PROM1
|
prominin 1
|
1.062
|
|
TRAF7
|
TNF receptor-associated factor 7, E3 ubiquitin protein ligase
|
1.062
|
|
NES
|
nestin
|
1.06
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
1.057
|
|
EZR
|
ezrin
|
1.057
|
|
GPR101
|
G protein-coupled receptor 101
|
1.052
|
|
TMEM67
|
transmembrane protein 67
|
1.051
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
1.051
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
1.048
|
|
CA2
|
carbonic anhydrase II
|
1.047
|
|
RNF139
|
ring finger protein 139
|
1.045
|
|
CDH13
|
cadherin 13
|
1.043
|
|
NDRG3
|
NDRG family member 3
|
1.042
|
|
GLI1
|
GLI family zinc finger 1
|
1.042
|
|
CLN5
|
ceroid-lipofuscinosis, neuronal 5
|
1.041
|
|
SLC16A4
|
solute carrier family 16, member 4
|
1.04
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.036
|
|
UBR1
|
ubiquitin protein ligase E3 component n-recognin 1
|
1.036
|
|
NTS
|
neurotensin
|
1.036
|
|
CDX2
|
caudal type homeobox 2
|
1.033
|
|
MARCHF6
|
membrane associated ring-CH-type finger 6
|
1.033
|
|
CUL7
|
cullin 7
|
1.029
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.023
|
|
RB1
|
retinoblastoma 1
|
1.021
|
|
GANAB
|
glucosidase, alpha; neutral AB
|
1.02
|
|
CA5B
|
carbonic anhydrase VB, mitochondrial
|
1.02
|
|
IL6
|
interleukin 6
|
1.018
|
|
GOT2
|
glutamic-oxaloacetic transaminase 2, mitochondrial
|
1.016
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
1.015
|
|
CISH
|
cytokine inducible SH2-containing protein
|
1.013
|
|
ZUP1
|
zinc finger containing ubiquitin peptidase 1
|
1.006
|
|
MMP9
|
matrix metallopeptidase 9
|
1.005
|
|
CDK2
|
cyclin-dependent kinase 2
|
1.004
|
|
EPCAM
|
epithelial cell adhesion molecule
|
1.001
|
|
MUC1
|
mucin 1, cell surface associated
|
1.0
|
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2
|
1.0
|
